In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin

British Journal of Cancer

Volumn 96, Issue 9, 2007, Pages 1404-1408

  Batistatou, A ^a   Peschos, D ^a   Tsanou, H ^a   Charalabopoulos, A ^b   Nakanishi, Y ^c   Hirohashi, S ^c   Agnantis, N J ^a   Charalabopoulos, K ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Peterborough and Stamford Hospitals ^*  (United Kingdom)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Breast; Ductal carcinoma; Dysadherin; E cadherin; Lobular carcinoma

Indexed keywords

DYSADHERIN; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR PROMOTION;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS;

EID: 34247578212     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603743     Document Type: Article

References (38)

1. Aoki S, Shimamura T, Shibata T, Nakanishi Y, Moriya Y, Sato Y, Kitajima M, Sakamoto M, Hirohashi S (2003) Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer 88: 726-732
2. Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K (2006) Expression patterns of dysadherin and E- cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch 448: 763-777
3. Batistatou A, Scopa CD, Ravazoula P, Nakanishi Y, Peschos D, Agnantis NJ, Hirohashi S, Charalabopoulos KA (2005) Involvement of dysadherin and E-cadherin in the development of testicular tumors. Br J Cancer 93: 1382-1387
4. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H (1994) E- cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852
5. Chang HW, Chow V, Lam KY, Wei WI, Yuen A (2002) Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94: 386-392
6. Charalabopoulos K, Binolis J, Karkabounas S (2002) Adhesion molecules in carcinogenesis. Exp Oncol 24: 249-257
7. Charalabopoulos K, Gogali A, Kostoula OK, Constantopoulos H (2004) Cadherin superfamily of adhesion molecules in primary lung cancer. Exp Oncol 16: 256-260
8. Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Choux R, Lavaut M (1997) E-cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol 431: 317-321
9. Elzagheid A, Kuopio T, Ilmen M, Collan Y (2002) Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining:the methodology and clinical relevance. Histopathology 41: 127-133
10. Gillett CE, Miles DW, Ryder K, Skilton D, Liebman RD, Springall RJ, Barnes DM, Hanby AM (2001) Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol 193: 433-441
11. Gupta A, Desphande CG, Badve S (2003) Role of E-cadherins in development of lymphatic tumor emboli. Cancer 97: 2341-2347
12. Heimann R, Lan F, McBride R, Hellman S (2000) Separating favourable from unfavourable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 60: 298-304
13. Hirohashi S (1998) Inactivation of E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339
14. Hirohashi S, Kanai Y (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581
15. Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V, Ingvarsson S (1999) Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 81: 1003-1010
16. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S (2002) Dysadherin, a cancer-associated cell membrane glycoprotein, downregulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 99: 365-370
17. Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S (1994) Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 85: 1035-1039
18. Knudsen KA, Wheelock MJ (2005) Cadherins and the mammary gland. J Cel Biol 95: 488-496
19. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ, Nakanishi Y, Hirohashi S, Charalabopoulos K (2006) Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 30: 185-193
20. Lubarski I, Pihakaski-Maunshbach K, Karlish SJ, Maunsbach AB, Garty H (2005) Interaction with the Na,K-Atpase and tissue distribution of FXYD5 (related to ion channel). J Biol Chem 280: 37717-37724
21. Massarelli E, Brown E, Tran NK, Liu DD, Izzo JG, Lee JJ, El-Naggar AK, Hong WK, Papadimitrakopoulou VA (2005) Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis. Cancer 103: 952-959
22. Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL (2005) E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 18: 741-751
23. Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M, Hirohashi S (2004) Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol 12: 323- 328
24. Nam J-S, Kang M-J, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S, Wakefield LM (2006) Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res 66: 7176-7184
25. Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S (2005) Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma. Cancer 103: 1693-1700
26. Oka H, Shiozaki H, Kabayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M (1993) Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701
27. Parker C, Rampaul RS, Pinder SE, Bell JA, Wencyk PM, Blamey RW, Nicholson RI, Robertson JF (2001) E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer 85: 1958-1963
28. Rakha EA, Abd El, Rehim D, Pinder SE, Lewis Sa, Ellis IO (2005) E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46: 685-693
29. Sarrio D, Perez-Mies B, Hardisson D, Moreno-Bueno G, Suarez A, Cano A, Martin-Perez J, Gamallo C, Palacios J (2004) Cytoplasmic localization of p120ctn and E_cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene 23: 3272-3283
30. Sato H, Ino Y, Miura A, Abe Y, Sakai H, Ito K, Hirohashi S (2003) Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab 88: 4407-4412
31. Shibata T, Kokubu A, Sekine S, Kanai Y, Hirohashi S (2004) Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin deficient breast cancer. Am J Pathol 164: 2269-2278
32. Shimada Y, Hashimoto Y, Kan T, Kawamura J, Okumura T, Soma T, Kondo K, Teratani N, Watanabe G, Ino Y, Sakamoto M, Hirohashi S, Imamura M (2004a) Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma. Oncology 67: 73-80
33. Shimada Y, Yamasaki S, Hashimoto Y, Ito T, Kawamura J, Soma T, Ino Y, Nakanishi Y, Sakamoto M, Hirohashi S, Imamura M (2004b) Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res 10: 2818-2823
34. Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S (2003) Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression. J Clin Oncol 21: 659-667
35. Shimamura T, Yasuda J, Ino Y, Gotoh M, Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y, Hirohashi S (2004) Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res 64: 6989-6995
36. Tsuiji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S (2002) Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. Glycobiology 13: 521-527
37. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast:an early event in tumorigenesis. Br J Cancer 76: 1131-1133
38. Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z (2004) Prognostic significance of dysadherin expression in cervical squamous cell carcinoma. Pathol Oncol Res 10: 212-218